Abiopharma

CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer

Nuvation Bio Inc. - Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib(IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers

OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities

New Form 8-K - PAVmed Inc. Filed: 2025-06-24 AccNo: 0001641172-25-016227 Size: 210 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

FDA approve FORMOTEROL FUMARATE; MOMETASONE FUROATE

MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

New Form 8-K - Ainos, Inc. Filed: 2025-06-24 AccNo: 0001641172-25-016226 Size: 278 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Semler Scientific, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-061946 Size: 194 KB Item 8.01: Other Events

New Form 8-K - SANGAMO THERAPEUTICS, INC Filed: 2025-06-24 AccNo: 0001628280-25-032748 Size: 164 KB Item 8.01: Other Events

New Form RW - Allarity Therapeutics, Inc. Filed: 2025-06-24 AccNo: 0001213900-25-056913 Size: 8 KB

Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products

Retirement Of Mr. Lee Keck Keong As Executive Director

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease